“Médecins Sans Frontières (MSF) states that, while Gavi has helped to lower prices of new and underused vaccines for eligible countries, the cost to fully immunise a child was 68 times more expensive in 2014 than it was in 2001”.
The report also questions why the Gates foundation invests heavily in companies like Monsanto and Bayer. “In addition to its grant-making activities, the Gates foundation has recently stepped up its support for the biotechnological industry directly.” In February, it took a $52m equity stake in CureVac, a German bio-pharmaceutical company.
“There is a revolving door between the Gates foundation and pharmaceutical corporations. Many of the foundation’s staff had held positions at pharmaceutical companies,” the report adds.